Arvinas CEO details stock and option holdings
Arvinas, Inc. President and CEO Randy Teel reports his direct holdings of common stock and stock options in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Arvinas, Inc. President and CEO Randy Teel reports his direct holdings of common stock and stock options in the company. The filing lists multiple option and restricted stock unit grants made between 2018 and 2025, with vesting schedules extending through 2029 and generally contingent on continued service. It also notes shares previously purchased under the 2018 Employee Stock Purchase Plan. The report does not show any stock purchases or sales, only existing equity awards and holdings.
Insider Trade Summary
16 transactions reported
Mixed
16 txns
Insider
Teel Randy
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 535,348 contracts (Direct);
Common Stock — 158,885 shares (Direct)
Footnotes (16)
- F1. Includes 1,509 shares of common stock of the Issuer previously purchased by the reporting person under the issuer's 2018 Employee Stock Purchase Plan.
- F2. The restricted stock units (each, an "RSU") were granted by the Issuer on May 9, 2025, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs vest over two years: 1/2 of the shares underlying the award will vest on May 9, 2026, with the remainder of the shares vesting on May 9, 2027, subject to the reporting person's continued service with the Issuer on each vesting date.
- F3. The RSUs were granted by the Issuer on February 13, 2025, pursuant to its Plan and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs vest over four years: 25% of the RSUs will vest on each of February 13, 2026, February 13, 2027, February 13, 2028 and February 13, 2029, subject to the reporting person's continued service with the Issuer on each vesting date.
- F4. The RSUs were granted by the Issuer on May 21, 2024, in connection with the reporting person being named as Chief Business Officer of the Issuer, pursuant to its Plan and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs vest over two years: 1/2 of the shares underlying the award vested on May 21, 2025, with the remainder of the shares vesting on May 21, 2026, subject to the reporting person's continued service with the Issuer on each vesting date. The RSU amount reflects that 2,228 shares were sold to pay for taxes following the May 21, 2025 vesting.
- F5. The RSUs were granted by the Issuer on February 23, 2024, pursuant to its Plan and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs vest over two years: 1/2 of the shares underlying the award vested on February 23, 2025, with the remainder of the shares vesting in on February 23, 2026, subject to the reporting person's continued service with the Issuer on each vesting date. The RSU amount reflects that 4,380 shares were sold to pay for taxes following the February 23, 2025 vesting.
- F6. The RSUs were granted by the Issuer on February 22, 2023, pursuant to the Plan and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs vest over four years: 25% of the RSUs vested on each of February 22, 2024 and February 22, 2025, with the remaining RSUs vesting on each of February 22, 2026 and February 22, 2027, subject to the reporting person's continued service with the Issuer on each vesting date. The RSU amount reflects that 1,184 and 1,125 shares were sold to pay for taxes following the February 22, 2024 and February 22, 29025 vestings, respectively.
- F7. The option was granted by the Issuer on May 9, 2025, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on May 9, 2026, with the remainder of the shares vesting on May 9, 2027, subject to the reporting person's continued service with the Issuer on each vesting date.
- F8. The option was granted by the Issuer on February 13, 2025, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award will vest on February 13, 2026, with the remainder of the shares vesting in equal monthly installments following February 13, 2026 through February 13, 2029, subject to the reporting person's continued service with the Issuer on each vesting date.
- F9. The option was granted by the Issuer on May 21, 2024, in connection with the reporting person being named as Chief Business Officer of the Issuer, pursuant to the Plan. The shares underlying the option vest over two years: 1/2 of the shares underlying the award vested on May 21, 2025, with the remainder of the shares vesting on May 21, 2026, subject to the reporting person's continued service with the Issuer on each vesting date.
- F10. The option was granted by the Issuer on February 23, 2024, pursuant to the Plan. The shares underlying the option vest over two years: 1/2 of the shares underlying the award vested on February 23, 2025, with the remainder of the shares vesting on February 23, 2026, subject to the reporting person's continued service with the Issuer on each vesting date.
- F11. The option was granted by the Issuer on February 22, 2023, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award vested on February 22, 2024, with the remainder of the shares vesting in equal monthly installments following February 22, 2024 through February 23, 2027, subject to the reporting person's continued service with the Issuer on each vesting date.
- F12. The option was granted by the Issuer on February 23, 2022, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award vested on February 23, 2023, with the remainder of the shares vesting in equal monthly installments following February 23, 2023 through February 23, 2026, subject to the reporting person's continued service with the Issuer on each vesting date.
- F13. The option was granted by the Issuer on February 26, 2021, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on February 26, 2022, and the remainder of the shares vested in equal monthly installments following February 23, 2022 through February 23, 2025.
- F14. The option was granted by the Issuer on February 27, 2020, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on February 27, 2021, and the remainder of the shares vested in equal monthly installments following February 27, 2021 through February 27, 2024.
- F15. The option was granted by the Issuer on March 1, 2019, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on March 1, 2020, and the remainder of the shares vested in equal monthly installments following March 1, 2020 through March 1, 2023.
- F16. The option was granted by the Issuer on September 26, 2018, pursuant to the Plan. The shares underlying the option vested over four years: 1/4 of the shares underlying the award vested on May 14, 2019, and the remainder of the shares vested in equal monthly installments following May 14, 2019 through May 14, 2022.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Randy Teel report owning in Arvinas (ARVN)?
Randy Teel reports direct holdings of Arvinas common stock and multiple stock options and restricted stock units. These equity awards were granted over several years and provide rights to receive or purchase Arvinas shares under specified vesting schedules and conditions.
Are there any stock purchases or sales in this Arvinas (ARVN) Form 3?
No purchases or sales are reported. The Form 3 lists Randy Teel’s existing holdings in common stock, stock options, and restricted stock units, along with vesting terms, rather than new open-market or other buy or sell transactions in Arvinas shares.
How do Randy Teel’s Arvinas (ARVN) RSUs vest over time?
The RSUs generally vest over two- or four-year periods, with portions vesting on specific dates such as May 9, 2026 and 2027, and February 13 from 2026 through 2029, each subject to Randy Teel’s continued service with Arvinas on the relevant vesting dates.
What stock option grants are disclosed for Randy Teel at Arvinas (ARVN)?
The filing details multiple stock option grants made between 2018 and 2025 under Arvinas’ 2018 Stock Incentive Plan. These options vest over two or four years, often with an initial 25% or 50% vesting on a set date and remaining portions vesting in monthly installments.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates